跳至主要内容
临床试验/NCT00269763
NCT00269763已完成3 期

The Clinical Use and Safety of TTS (Fentanyl) in the Management of Pain in Patients With Cancer

Alza Corporation, DE, USA0 个研究点目标入组 32 人开始时间: 2005年12月26日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
32
主要终点
Assessment of pain relief; Rescue medication usage

研究概览

简要总结

The purpose of this study is to establish the clinical utility and safety of fentanyl TTS (a transdermal patch delivering the narcotic pain reliever fentanyl) in the treatment of pain in patients with cancer.

详细描述

This is a single-arm, non-randomized, open-label, multi-center trial to assess the safety and clinical utility of the fentanyl Transdermal Therapeutic System (TTS) for the treatment of pain in patients with cancer. Patients requiring narcotics for pain management are converted from conventional analgesics to oral morphine, and titrated to a stable dose prior to the initiation of fentanyl TTS. The stabilized morphine dose provides the basis for the calculation of the equi-analgesic dose of fentanyl TTS based on established analgesic potency ratios. Patients replace the fentanyl TTS patch every 3 days. Immediate-release morphine is available as rescue medication for breakthrough pain. The adequacy of analgesia, use of morphine rescue medication, and routine safety evaluations are obtained at scheduled intervals throughout the trial.

fentanyl patch

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients currently taking narcotic analgesics for relief of cancer pain
  • Able to communicate effectively
  • Living with a constant caretaker
  • Who have achieved a stabilized morphine dose that provides adequate pain control

排除标准

  • Patients with a life expectancy of less than 30 days
  • Having history of carbon dioxide (CO2) retention or other cardiac, respiratory or nervous system disease (precludes participation because of the potential for respiratory depression)
  • Has severe renal or hepatic insufficiency, active skin disease, a history of allergic reactions to narcotics, or a history of narcotic abuse prior to treatment with narcotics for cancer-related pain
  • Has a mental or psychiatric disease
  • If female of child-bearing potential, currently pregnant or not practicing an acceptable method contraception

结局指标

主要结局

Assessment of pain relief; Rescue medication usage

次要结局

  • Incidence and severity of adverse events

研究者

发起方
Alza Corporation, DE, USA
申办方类型
Industry

相似试验